Digestive Diseases Branch, National Institutes of Health, Bethesda, MD, USA.
Aliment Pharmacol Ther. 2013 Jun;37(12):1198-209. doi: 10.1111/apt.12325. Epub 2013 May 3.
Gastro-oesophageal reflux disease (GERD) and gastric acid hypersecretion respond well to suppression of gastric acid secretion. However, clinical management and research in diseases of acid secretion have been hindered by the lack of a non-invasive, accurate and reproducible tool to measure gastric acid output (GAO). Thus, symptoms or, in refractory cases, invasive testing may guide acid suppression therapy.
To present and validate a novel, non-invasive method of GAO analysis in healthy subjects using a wireless pH sensor, SmartPill (SP) (SmartPill Corporation, Buffalo, NY, USA).
Twenty healthy subjects underwent conventional GAO studies with a nasogastric tube. Variables impacting liquid meal-stimulated GAO analysis were assessed by modelling and in vitro verification. Buffering capacity of Ensure Plus was empirically determined. SP GAO was calculated using the rate of acidification of the Ensure Plus meal. Gastric emptying scintigraphy and GAO studies with radiolabelled Ensure Plus and SP assessed emptying time, acidification rate and mixing. Twelve subjects had a second SP GAO study to assess reproducibility.
Meal-stimulated SP GAO analysis was dependent on acid secretion rate and meal-buffering capacity, but not on gastric emptying time. On repeated studies, SP GAO strongly correlated with conventional basal acid output (BAO) (r = 0.51, P = 0.02), maximal acid output (MAO) (r = 0.72, P = 0.0004) and peak acid output (PAO) (r = 0.60, P = 0.006). The SP sampled the stomach well during meal acidification.
SP GAO analysis is a non-invasive, accurate and reproducible method for the quantitative measurement of GAO in healthy subjects. SP GAO analysis could facilitate research and clinical management of GERD and other disorders of gastric acid secretion.
胃食管反流病(GERD)和胃酸分泌过多对胃酸分泌的抑制反应良好。然而,由于缺乏一种非侵入性、准确和可重复的测量胃酸分泌量(GAO)的工具,疾病的临床管理和研究受到了阻碍。因此,症状或在难治性病例中,侵入性测试可能会指导酸抑制治疗。
介绍并验证一种使用无线 pH 传感器 SmartPill(SP)(SmartPill Corporation,纽约州布法罗,美国)对健康受试者进行 GAO 分析的新的非侵入性方法。
20 名健康受试者接受了经鼻胃管进行的常规 GAO 研究。通过建模和体外验证评估了影响液体餐刺激 GAO 分析的变量。通过经验确定了 Ensure Plus 的缓冲能力。使用 Ensure Plus 餐的酸化速率计算 SP GAO。胃排空闪烁扫描和使用放射性标记的 Ensure Plus 和 SP 进行的 GAO 研究评估了排空时间、酸化率和混合。12 名受试者进行了第二次 SP GAO 研究以评估重复性。
餐刺激 SP GAO 分析依赖于胃酸分泌率和餐液缓冲能力,但与胃排空时间无关。在重复研究中,SP GAO 与常规基础胃酸分泌量(BAO)(r=0.51,P=0.02)、最大胃酸分泌量(MAO)(r=0.72,P=0.0004)和峰值胃酸分泌量(PAO)(r=0.60,P=0.006)呈强相关性。SP 在餐液酸化过程中很好地采样了胃。
SP GAO 分析是一种非侵入性、准确和可重复的方法,可用于健康受试者 GAO 的定量测量。SP GAO 分析可以促进 GERD 和其他胃酸分泌障碍的研究和临床管理。